Drug Trial Radar · NCT03472469
MAST Trial: Multi-modal Analgesic Strategies in Trauma
Last checked: Nov 19, 2026Latest source record: Jun 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,561
Actual
Start
Apr 2, 2018
Primary completion
Jul 3, 2019
Study completion Jul 3, 2019
Sponsor
- Lead sponsor
- The University of Texas Health Science Center, HoustonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Center for Advancing Translational Sciences (NCATS)
- First posted
- Mar 21, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a comparative effectiveness study of current pain management strategies in acutely injured trauma patients. Two different multi-modal, opioid minimizing analgesic strategies will be compared \[original multimodal pain regimen (MMPR) compared to multi-modal analgesic strategies for trauma (MAST) MMPR\].
Conditions
- Nonspecific Pain Post Traumatic Injury
Interventions
Acetaminophen IV/PODrug
Acetaminophen 1g IV/PO every 6 hours
Acetaminophen PODrug
Acetaminophen 1g PO every 6 hours
KetorolacDrug
Ketorolac 30mg IV once
CelebrexDrug
Celebrex 200mg PO every 12 hours
NaproxenDrug
Naproxen 500mg PO every 12 hours
TramadolDrug
Tramadol 100mg PO every 6 hours
PregabalinDrug
Pregabalin 100mg PO every 8 hours
GabapentinDrug
Gabapentin 300mg PO every 8 hours
LidocaineDrug
Lidocaine patch every 12 hours
OpioidsDrug
Opioid options include: Oral Opioids (Codeine, Tramadol, Hydrocodone, Oxycodone, Methadone, Morphine, Hydromorphone); Transdermal Opioid (Fentanyl); Intravenous Opioids (Morphine, Hydromorphone, Fentanyl)
Regional anesthesiaDrug
Regional anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Opioid Use Per DayTime frame: until discharge from hospital or 30 days post admission (whichever is sooner)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The University of Texas Health Science Center at Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.